• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过募集代偿途径以在肉碱棕榈酰转移酶I活性降低的情况下维持氧化通量,这是肥厚型心脏能量代谢效率低下的特征。

Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.

作者信息

Sorokina Natalia, O'Donnell J Michael, McKinney Ronald D, Pound Kayla M, Woldegiorgis Gebre, LaNoue Kathryn F, Ballal Kalpana, Taegtmeyer Heinrich, Buttrick Peter M, Lewandowski E Douglas

机构信息

Center for Cardiovascular Research, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612, USA.

出版信息

Circulation. 2007 Apr 17;115(15):2033-41. doi: 10.1161/CIRCULATIONAHA.106.668665. Epub 2007 Apr 2.

DOI:10.1161/CIRCULATIONAHA.106.668665
PMID:17404155
Abstract

BACKGROUND

Transport rates of long-chain free fatty acids into mitochondria via carnitine palmitoyltransferase I relative to overall oxidative rates in hypertrophied hearts remain poorly understood. Furthermore, the extent of glucose oxidation, despite increased glycolysis in hypertrophy, remains controversial. The present study explores potential compensatory mechanisms to sustain tricarboxylic acid cycle flux that resolve the apparent discrepancy of reduced fatty acid oxidation without increased glucose oxidation through pyruvate dehydrogenase complex in the energy-poor, hypertrophied heart.

METHODS AND RESULTS

We studied flux through the oxidative metabolism of intact adult rat hearts subjected to 10 weeks of pressure overload (hypertrophied; n=9) or sham operation (sham; n=8) using dynamic 13C-nuclear magnetic resonance. Isolated hearts were perfused with [2,4,6,8,10,12,14,16-(13)C8] palmitate (0.4 mmol/L) plus glucose (5 mmol/L) in a 14.1-T nuclear magnetic resonance magnet. At similar tricarboxylic acid cycle rates, flux through carnitine palmitoyltransferase I was 23% lower in hypertrophied (P<0.04) compared with sham hearts and corresponded to a shift toward increased expression of the L-carnitine palmitoyltransferase I isoform. Glucose oxidation via pyruvate dehydrogenase complex did not compensate for reduced palmitate oxidation rates. However, hypertrophied rats displayed an 83% increase in anaplerotic flux into the tricarboxylic acid cycle (P<0.03) that was supported by glycolytic pyruvate, coincident with increased mRNA transcript levels for malic enzyme.

CONCLUSIONS

In cardiac hypertrophy, fatty acid oxidation rates are reduced, whereas compensatory increases in anaplerosis maintain tricarboxylic acid cycle flux and account for a greater portion of glucose oxidation than previously recognized. The shift away from acetyl coenzyme A production toward carbon influx via anaplerosis bypasses energy, yielding reactions contributing to a less energy-efficient heart.

摘要

背景

相对于肥厚心脏中的整体氧化速率,长链游离脂肪酸通过肉碱棕榈酰转移酶I进入线粒体的转运速率仍知之甚少。此外,尽管肥大时糖酵解增加,但葡萄糖氧化的程度仍存在争议。本研究探讨了维持三羧酸循环通量的潜在代偿机制,这些机制解决了能量匮乏的肥大心脏中脂肪酸氧化减少而葡萄糖氧化未增加的明显差异,这一差异是通过丙酮酸脱氢酶复合体体现的。

方法与结果

我们使用动态13C核磁共振研究了完整成年大鼠心脏在经历10周压力超负荷(肥大;n = 9)或假手术(假手术;n = 8)后的氧化代谢通量。在14.1-T核磁共振磁体中,用[2,4,6,8,10,12,14,16-(13)C8]棕榈酸(0.4 mmol/L)加葡萄糖(5 mmol/L)灌注离体心脏。在相似的三羧酸循环速率下,与假手术心脏相比,肥大心脏中通过肉碱棕榈酰转移酶I的通量降低了23%(P<0.04),这与L-肉碱棕榈酰转移酶I同工型表达增加的转变相对应。通过丙酮酸脱氢酶复合体的葡萄糖氧化并未补偿棕榈酸氧化速率的降低。然而,肥大的大鼠进入三羧酸循环的回补通量增加了83%(P<0.03),这由糖酵解产生的丙酮酸支持,同时苹果酸酶的mRNA转录水平增加。

结论

在心脏肥大中,脂肪酸氧化速率降低,而回补的代偿性增加维持了三羧酸循环通量,并且葡萄糖氧化的占比高于先前的认识。从乙酰辅酶A生成向通过回补的碳流入的转变绕过了能量产生反应,导致心脏能量效率降低。

相似文献

1
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.通过募集代偿途径以在肉碱棕榈酰转移酶I活性降低的情况下维持氧化通量,这是肥厚型心脏能量代谢效率低下的特征。
Circulation. 2007 Apr 17;115(15):2033-41. doi: 10.1161/CIRCULATIONAHA.106.668665. Epub 2007 Apr 2.
2
Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats.左旋肉碱对糖尿病大鼠分离的心肌细胞中葡萄糖和脂肪酸代谢的作用减弱。
Horm Metab Res. 1997 Sep;29(9):430-5. doi: 10.1055/s-2007-979071.
3
Gender and post-ischemic recovery of hypertrophied rat hearts.性别与肥大大鼠心脏缺血后的恢复
BMC Cardiovasc Disord. 2006 Mar 1;6:8. doi: 10.1186/1471-2261-6-8.
4
Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy.急性肝肉毒碱棕榈酰基转移酶 I 过表达重现心脏肥大时棕榈酸氧化减少。
Circ Res. 2013 Jan 4;112(1):57-65. doi: 10.1161/CIRCRESAHA.112.274456. Epub 2012 Sep 14.
5
Stimulation of non-oxidative glucose utilization by L-carnitine in isolated myocytes.左旋肉碱对分离心肌细胞非氧化葡萄糖利用的刺激作用。
J Mol Cell Cardiol. 1995 Nov;27(11):2465-72. doi: 10.1006/jmcc.1995.0234.
6
Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.在分离的心肌细胞中,葡萄糖利用产生的乙酰辅酶A对脂肪酸氧化的调节作用。
J Mol Cell Cardiol. 1996 May;28(5):825-33. doi: 10.1006/jmcc.1996.0077.
7
L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts.左旋肉碱对心脏功能的改善与肉碱缺乏心脏中葡萄糖代谢的刺激有关,而与脂肪酸代谢无关。
Cardiovasc Res. 1995 Nov;30(5):815-20.
8
Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.与慢性多柔比星心肌病相关的代谢重塑。
Toxicology. 2010 Apr 11;270(2-3):92-8. doi: 10.1016/j.tox.2010.01.019. Epub 2010 Feb 1.
9
Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine.容量超负荷大鼠心脏氧化代谢的调控:丙酰-L-肉碱的作用
Am J Physiol. 1997 Apr;272(4 Pt 2):H1615-24. doi: 10.1152/ajpheart.1997.272.4.H1615.
10
Thyroid hormone controls myocardial substrate metabolism through nuclear receptor-mediated and rapid posttranscriptional mechanisms.甲状腺激素通过核受体介导和快速转录后机制控制心肌底物代谢。
Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E372-9. doi: 10.1152/ajpendo.00288.2005. Epub 2005 Oct 4.

引用本文的文献

1
The Role of Mitophagy in Cardiac Metabolic Remodeling of Heart Failure: Insights of Molecular Mechanisms and Therapeutic Prospects.线粒体自噬在心力衰竭心脏代谢重塑中的作用:分子机制与治疗前景的见解
J Cardiovasc Transl Res. 2025 Mar 26. doi: 10.1007/s12265-025-10606-1.
2
Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics.心力衰竭中的回补反应:机制与潜在治疗方法综述
Cardiovasc Res. 2024 Dec 31;120(17):2166-2178. doi: 10.1093/cvr/cvae248.
3
Characterization of ferroptosis-triggered pyroptotic signaling in heart failure.
心力衰竭中铁死亡触发细胞焦亡信号的特征。
Signal Transduct Target Ther. 2024 Sep 25;9(1):257. doi: 10.1038/s41392-024-01962-6.
4
Aerobic exercise-induced HIF-1α upregulation in heart failure: exploring potential impacts on MCT1 and MPC1 regulation.有氧运动诱导心力衰竭中低氧诱导因子-1α上调:探索对单羧酸转运蛋白1和线粒体丙酮酸载体1调节的潜在影响。
Mol Med. 2024 Jun 12;30(1):83. doi: 10.1186/s10020-024-00854-3.
5
UCP1-dependent brown adipose activation accelerates cardiac metabolic remodeling and reduces initial hypertrophic and fibrotic responses to pathological stress.UCP1 依赖性棕色脂肪组织激活加速心脏代谢重塑,并减少病理性应激引起的初始肥大和纤维化反应。
FASEB J. 2024 Jun 15;38(11):e23709. doi: 10.1096/fj.202400922R.
6
Elevated Na is a dynamic and reversible modulator of mitochondrial metabolism in the heart.血钠升高是心脏中线粒体代谢的一种动态和可逆的调节剂。
Nat Commun. 2024 May 20;15(1):4277. doi: 10.1038/s41467-024-48474-z.
7
Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice.在射血分数降低的心肌肥厚和心力衰竭中,代谢重塑在小鼠体内独立于转录因子EB发生。
Front Cardiovasc Med. 2024 Jan 8;10:1323760. doi: 10.3389/fcvm.2023.1323760. eCollection 2023.
8
Role of STIM1 in the Regulation of Cardiac Energy Substrate Preference.STIM1 在调节心脏能量底物偏好中的作用。
Int J Mol Sci. 2023 Aug 25;24(17):13188. doi: 10.3390/ijms241713188.
9
Metabolic flux in the driver's seat during cardiac health and disease.心脏健康与疾病中的代谢流:驾驶员的位置。
J Mol Cell Cardiol. 2023 Sep;182:15-24. doi: 10.1016/j.yjmcc.2023.07.004. Epub 2023 Jul 13.
10
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges.生理和病理性心肌肥厚中的代谢机制:新范例和挑战。
Nat Rev Cardiol. 2023 Dec;20(12):812-829. doi: 10.1038/s41569-023-00887-x. Epub 2023 May 26.